Patents by Inventor Sujung Song

Sujung Song has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of Cancers with Micro-RNA Inhibitors
    Publication number: 20180105813
    Abstract: The invention relates to the treatment and prevention of cancers, including blood-based cancers and breast cancers, by administering agents that inhibit the activity of microRNAs, including miR-22. Inhibitors can include oligonucleotides that are at least partially complementary to these miRNAs. In some embodiments, these inhibitors are chemically modified oligonucleotides, including locked nucleic acids (LNAs).
    Type: Application
    Filed: October 4, 2017
    Publication date: April 19, 2018
    Inventors: Pier Paolo Pandolfi, Sujung Song
  • Treatment of cancers with micro-RNA inhibitors
    Patent number: 9822358
    Abstract: The invention relates to the treatment and prevention of cancers, including blood-based cancers and breast cancers, by administering agents that inhibit the activity of microRNAs, including miR-22. Inhibitors can include oligonucleotides that are at least partially complementary to these miRNAs. In some embodiments, these inhibitors are chemically modified oligonucleotides, including locked nucleic acids (LNAs).
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: November 21, 2017
    Assignee: BETH ISRAEL DEACONESS MEDICAL CENTER
    Inventors: Pier Paolo Pandolfi, Sujung Song
  • TREATMENT OF CANCERS WITH MICRO-RNA INHIBITORS
    Publication number: 20150111949
    Abstract: The invention relates to the treatment and prevention of cancers, including blood-based cancers and breast cancers, by administering agents that inhibit the activity of microRNAs, including miR-22. Inhibitors can include oligonucleotides that are at least partially complementary to these miRNAs. In some embodiments, these inhibitors are chemically modified oligonucleotides, including locked nucleic acids (LNAs).
    Type: Application
    Filed: October 17, 2014
    Publication date: April 23, 2015
    Inventors: Pier Paolo Pandolfi, Sujung Song